Skip to content

Study in Leucocytes From Patients With Type 1 and Type 2 Diabetes Genetic Markers of Inflammation and Oxidative Stress (TÉLOMÈRES/ CANDIDATE GENES) According to the Type A or Type B Behavior Profile

Study in Leucocytes From Patients With Type 1 and Type 2 Diabetes Genetic Markers of Inflammation and Oxidative Stress (TÉLOMÈRES/ CANDIDATE GENES) According to the Type A or Type B Behavior Profile

Status
Terminated
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02080741
Acronym
Diatolepsy
Enrollment
57
Registered
2014-03-06
Start date
2014-09-23
Completion date
Unknown
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients With a Type A or B Behaviour Profile, Patients With Type 1 or Type 2 Diabetes

Brief summary

This study will include 100 patients with Type 1 and Type 2 diabetes, split into 2 groups of 50 patients according to their behaviour type, and their adaptation to different factors of stress encountered in their lives: * the first group will consist of patients with a characteristic Type A behaviour profile, that is to say patients with a "proactive, impatient" behaviour pattern * the second group will consist of patients with a characteristic Type B behaviour profile that is to say patients with a "calm, slow" behaviour pattern The objective is to know if the different behaviour patterns are associated with distinct biological markers likely to influence the evolution of the diabetes. Participation in this study will be approximately 1h30, patients will participate ONCE ONLY: 1. they will answer simple questions about their disease and then complete 3 questionnaires each with 14 items. 2. they will meet a clinical psychologist for an interview lasting approximately 45 minutes recorded on an audio recorder. The consultation will be used to seek links between the psyche and the disease. 3. they will provide one blood sample of 12 ml (equivalent to a soup spoon) drawn in the morning.

Interventions

OTHERBlood sample of 12 ml

Sponsors

Centre Hospitalier Universitaire Dijon
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients who have provided written informed consent * Patients with type 1 or type 2 diabetes * Patient admitted for a consultation, as out or in-patients to the Endocrinology-Diabetology-Metabolic diseases department of Dijon CHU * Patient \> 18 years * Patient with either a characteristic Type A behaviour profile (Bortner \> 210), or a characteristic Type B behaviour profile (Bortner\<154)

Exclusion criteria

* Persons not covered by national health insurance * Adults under guardianship or wards of court or not intellectually independent * Patients without diabetes * Patients with a mixed A/B behaviour profile (154\< Bortner score \<210) * Pregnant or breast-feeding women

Design outcomes

Primary

MeasureTime frame
Telomere lengthBaselines

Secondary

MeasureTime frame
Level of expression of candidate genesBaselines

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026